Jul 12, 2021, 01:00 by admin admin

ASAM sent a letter to congress members thanking them for their introduction of H.R 1693 / S. 79, the Eliminating a Quantifiably Unjust Application of the Law Act. This legislation would eliminate the federal crack and powder cocaine sentencing disparity and apply it retroactively to those already convicted or sentenced

Jul 12, 2021, 01:00 by admin admin

At its May 2021 meeting, the American Medical Association’s (AMA) Current Procedural Terminology (CPT)® Editorial Panel created two new category III CPT codes for digital cognitive behavioral therapy (CBT) services, a step forward toward creating a structure that will allow patients to access these therapies.

Jul 6, 2021, 01:00 by admin admin

ASAM provided input on the Office of National Drug Control Policy's (ONDCP) 2022 National Drug Control Strategy by urging ONDCP to take action to strengthen the addiction medicine workforce, standardize the delivery of individualized addiction care, ensure equitable access and coverage for comprehensive, high-quality addiction care, and reduce barriers to accessing evidence-based addiction treatment.

Jul 2, 2021, 01:00 by admin admin

The Coalition to Stop Opioid Overdose (CSOO) and the Mental Health Liaison Group (MHLG) hosted a virtual roundtable with Congressman Kevin Hern (R-OK) to discuss legislative efforts by Congress to alleviate addiction and mental health challenges during the public health emergency.

Jun 25, 2021, 01:00 by admin admin

The New Jersey Society of Addiction Medicine (NJSAM), Shatterproof, and 5 other organizations sent a letter to Governor Phil Murphy urging him to sign S3867/A5868, which would create the Opioid Recovery and Remediation Fund for use by the New Jersey legislature in combatting the state’s addiction crisis.

Jun 22, 2021, 01:00 by admin admin

ASAM submitted comments in response to a section of a proposed rule from the Centers for Medicare and Medicaid Services (CMS) intended to implement a provision of the Consolidated Appropriations Act of 2021 which created 1,000 additional Medicare-supported graduate medical education (GME) positions.

Jun 22, 2021, 01:00 by admin admin

Jun 22, 2021, 01:00 by admin admin

The New York Society of Addiction Medicine (NYSAM) sent a letter to Governor Andrew Cuomo urging him to sign SB1795, which would expand access to addiction treatment in criminal justice settings.

Jun 17, 2021, 01:00 by admin admin

The Michigan Society of Addiction Medicine (MISAM) sent a letter to legislators in support of SB436, which would allow a county medical examiner or county health officer to establish a drug-fatality review team.

Jun 12, 2021, 01:00 by admin admin

Jun 8, 2021, 01:00 by admin admin

The $28 million program launched by the Health Resources and Services Administration today is a major step forward in strengthening the nation’s addiction treatment workforce at a critical juncture in America’s overdose epidemic.

Jun 7, 2021, 02:00 by admin admin

Every spring, state and territorial quit lines—a mainstay of tobacco use reduction efforts—get a spike in calls. The bump comes from the annual Tips from Former Smokers campaign, a US Centers for Disease Control and Prevention initiative that tells gripping stories of people who suffer with life-altering conditions because of smoking.

Jun 1, 2021, 01:00 by admin admin

ASAM sent a letter in support of H.R. 2503, the Social Determinants Accelerator Act of 2021, which would create an inter-agency technical advisory council on social determinants of health (SDOH) and a new federal grant program to assist state, local, and Tribal governments in tackling persistent economic and social conditions that impact the prevention and treatment of chronic medical conditions, including addiction.

May 24, 2021, 01:00 by admin admin

ASAM leaders Dr. Yngvild Olsen and Dr. Jeff Selzer served as ASAM representatives and subject matter experts on the FSMB Workgroup that developed the newly approved Policy on Physician Illness and Impairment: Towards a Model that Optimizes Patient Safety and Physician Health.

May 21, 2021, 01:00 by admin admin

On May 21, the American Society of Addiction Medicine (ASAM) and 228 other organizations sent a letter urging legislators to include $120 million for the Infectious Diseases and the Opioid Epidemic program in the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies' appropriations bills.

Apr 30, 2021, 01:00 by admin admin

ASAM sent a letter to the U.S. Department of Health and Human Services (HHS) to provide comments on the proposed modifications to the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, intended to support, and remove barriers to, coordinated care and individual engagement.

Apr 29, 2021, 01:00 by admin admin

ASAM urges FDA to propose and finalize regulations expeditiously to implement this bold proposal that will protect youth against tobacco use initiation, reduce health disparities, and save lives

Apr 28, 2021, 01:00 by admin admin

The Midwest Society of Addiction Medicine (MWSAM) submitted a letter of support for SB521, which would require that state entities in Missouri responsible for individuals who are incarcerated provide screening and assessment for substance use disorder (SUD), as well as access to various forms of medications for addiction treatment (MAT).

Apr 27, 2021, 01:00 by admin admin

ASAM commends the reintroduction of the Opioid Workforce Act, which would expand the physician workforce by providing support for 1,000 new graduate medical education training positions over five years in hospitals that have—or are in the process of establishing—accredited residency programs in addiction medicine, addiction psychiatry, or pain medicine.

Apr 27, 2021, 01:00 by admin admin

The new policy exempts eligible, DEA-registered practitioners from federal certification requirements related to training, counseling, and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine – a step toward helping Americans with opioid use disorder access evidence-based addiction care.